Kelly Kersten

Assistant Professor

Sanford Burnham Prebys Medical Discovery Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kelly Kersten is an Assistant Professor at the Sanford Burnham Prebys Medical Discovery Institute in the United States. Her research focuses on the interactions between tumor-associated macrophages and immune cells, particularly in breast cancer, exploring the metabolic reprogramming and immune responses in the tumor microenvironment. Recent publications highlight her investigations into immune checkpoint blockade and the mechanisms of immune suppression in cancer. Through her work, she aims to enhance therapeutic efficacy and provide insights for the next generation of cancer researchers.

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (16)

Kristin G Anderson

Assistant Professor

University of Virginia

UNITED STATES

Kelly Kersten

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis

Tumor-associated macrophages restrict CD8<sup>+</sup> T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment

Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium

Neoadjuvant immune checkpoint blockade triggers persistent and systemic T<sub>reg</sub> activation which blunts therapeutic efficacy against metastatic spread of breast tumors

Uptake of tumor-derived microparticles induces metabolic reprogramming of macrophages in the early metastatic lung

IL-5-producing CD4<sup>+</sup> T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer.

MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling.

Spatiotemporal co-dependency between macrophages and exhausted CD8<sup>+</sup> T cells in cancer

An expanded universe of cancer targets

Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune system

Collaborators (16)

Kristin G Anderson

Wilbert Zwart

Evan Lind

Neil Tay

Matthew F. Krummel

Martin Eilers

Joel Bader

Carlos Moreno

Calvin Kuo

Olga Isaeva

Huy Dinh

Zinaida Good

Hannah Garner

Ken Chen

Dan Kaufman

Laura Evgin

Make your next move.